Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB26FYM40
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,565
Award facts
- Contract value 100% obligated
- $9,564.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,564.66 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and will serve as the sole contractor on this award with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide. The underlying PPV-G GEN V contract, valued at $499.9 million with a completion date of December 31, 2036, establishes DMS Pharmaceutical Group as a regional prime vendor contractor authorized to fulfill diverse pharmaceutical requirements including branded and generic prescription drugs, biologics, and medical consumables. The vendor's extensive performance history across multiple therapeutic categories and product lines demonstrates its capability to support the recurring medical supply needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FYM40?
SPE2DB26FYM40 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FYM40 worth?
The government has obligated $9,565 on SPE2DB26FYM40.
Is contract SPE2DB26FYM40 an order under another contract?
Yes. SPE2DB26FYM40 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM40 competed?
The extent of competition for SPE2DB26FYM40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award